Table 1 Demographic characteristics of patients
From: Improvement of refractory migraine headache by propofol: case series
Case | Gender | Age | VAS at presenting | VAS at discharge | Administered dose of propofol (mg) | Required time until palliation of headache (min) | Co-existing symptoms |
|---|---|---|---|---|---|---|---|
1 | Male | 22 | 10/10 | 2/10 | 50 | 25 | Nausea, vomiting, photophobia |
2 | Female | 44 | 9/10 | 0/10 | 10 | 5 | Nausea |
3 | Female | 35 | 8/10 | 2/10 | 20 | 10 | Nausea, vomiting, photo/phonophobia |
4 | Female | 28 | 10 /10 | 1/10 | 20 | 10 | Nausea |
5 | Female | 25 | 8/10 | 1/10 | 30 | 15 | Nausea, vomiting, photo/phonophobia |
6 | Male | 28 | 8/10 | 0/10 | 30 | 15 | Nausea |
7 | Female | 32 | 9/10 | 1/10 | 20 | 10 | Nausea, vomiting |
8 | Female | 30 | 9/10 | 2/10 | 60 | 30 | Nausea, vomiting, photo/phonophobia |